Influence of obstructive sleep apnea on serum butyrylcholinesterase activity and ischemia-modified albumin levels

Clinics

Volumn 68, Issue 7, 2013, Pages 968-973

  Yang, Liu Xue ^a,b   Ma, Shao Gang ^c   Liu, Hong ^c   Xu, Wei ^c  

^a GUANGXI MEDICAL UNIVERSITY   (China)

^b GUILIN MEDICAL UNIVERSITY   (China)

^c XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Biomarker; Butyrylcholinesterase; Ischemia modified albumin; Obstructive sleep apnea

Indexed keywords

BIOLOGICAL MARKER; CHOLINESTERASE; ISCHEMIA MODIFIED ALBUMIN; ISCHEMIA-MODIFIED ALBUMIN; SERUM ALBUMIN;

ADULT; AGED; ARTICLE; BLOOD; BODY MASS; CASE CONTROL STUDY; FEMALE; HUMAN; MALE; MIDDLE AGED; POSITIVE END EXPIRATORY PRESSURE; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; REGRESSION ANALYSIS; RISK FACTOR; SLEEP DISORDERED BREATHING;

ADULT; AGED; BIOLOGICAL MARKERS; BODY MASS INDEX; BUTYRYLCHOLINESTERASE; CASE-CONTROL STUDIES; CONTINUOUS POSITIVE AIRWAY PRESSURE; FEMALE; HUMANS; MALE; MIDDLE AGED; REFERENCE VALUES; REGRESSION ANALYSIS; RISK FACTORS; ROC CURVE; SERUM ALBUMIN; SLEEP APNEA, OBSTRUCTIVE;

EID: 84881052290     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.6061/clinics/2013(07)13     Document Type: Article

References (23)

1. Fava C, Montagnana M, Favaloro EJ, Guidi GC, Lippi G. Obstructive sleep apnea syndrome and cardiovascular diseases. Semin Thromb Hemost. 2011;37(3):280-97, http://dx.doi.org/10.1055/s-0031-1273092.
2. Lindberg E, Berne C, Franklin KA, Svensson M, Janson C. Snoring and daytime sleepiness as risk factors for hypertension and diabetes in women-a population-based study. Respir Med. 2007;101(6):1283-90, http://dx.doi.org/10.1016/j.rmed.2006.10.015.
3. Lavie L, Lavie P. Molecular mechanisms of cardiovascular disease in OSAHS: the oxidative stress link. Eur Respir J. 2009;33(6):1467-84, http://dx.doi.org/10.1183/09031936.00086608.
4. Tamaki S, Yamauchi M, Fukuoka A, Makinodan K, Koyama N, Tomoda K, et al. Production of inflammatory mediators by monocytes in patients with obstructive sleep apnea syndrome. Intern Med. 2009;48(15):1255-62, http://dx.doi.org/10.2169/internalmedicine.48.2366.
5. Lee SD, Ju G, Choi JA, Kim JW, Yoon IY. The association of oxidative stress with central obesity in obstructive sleep apnea. Sleep Breath. 2012;16(2):511-7, http://dx.doi.org/10.1007/s11325-011-0536-7.
6. Alzoghaibi MA, Bahammam AS. The effect of one night of continuous positive airway pressure therapy on oxidative stress and antioxidant defense in hypertensive patients with severe obstructive sleep apnea. Sleep Breath 2012;16(2):499-504.
7. Alonso-Fernández A, García-Río F, Arias MA, Hernanz A, de la Peña M, Piérola J, et al. Effects of CPAP on oxidative stress and nitrate efficiency in sleep apnea: a randomised trial. Thorax. 2009;64(7):581-6, http://dx. doi.org/10.1136/thx.2008.100537.
8. Massoulié J, Pezzementi L, Bon S, Krejci E, Vallette FM. Molecular and cellular biology of cholinesterases. Prog Neurobiol. 1993;41(1):31-91, http://dx.doi.org/10.1016/0301-0082(93)90040-Y.
9. Stojanov M, Stefanović A, Džingalašević G, Mandić-Radić S, Prostran M. Butyrylcholinesterase activity in young men and women: association with cardiovascular risk factors. Clin Biochem. 2011;44(8-9):623-6, http://dx.doi.org/10.1016/j.clinbiochem.2011.03.028.
10. Omu AE, Al-Azemi MK, Omu FE, Fatinikun T, Abraham S, George S, et al. Butyrylcholinesterase activity in women with diabetes mellitus in pregnancy: correlation with antioxidant activity. J Obstet Gynaecol. 2010;30(2):122-6, http://dx.doi.org/10.3109/01443610903443913.
11. Das UN. Acetylcholinesterase and butyrylcholinesterase as possible markers of low-grade systemic inflammation. Med Sci Monit. 2007;13(12):RA214-21.
12. Ma SG, Xu W, Wei CL, Wu XJ, Hong B, Wang ZJ, et al. Role of ischemiamodified albumin and total homocysteine in estimating symptomatic lacunar infarction in type 2 diabetic patients. Clin Biochem. 2011;44(16):1299-1303, http://dx.doi.org/10.1016/j.clinbiochem.2011.08. 1136.
13. Chen CY, Tsai WL, Lin PJ, Shiesh SC. The value of serum ischemiamodified albumin for assessing liver function in patients with chronic liver disease. Clin Chem Lab Med. 2011;49(11):1817-21.
14. Turedi S, Cinar O, Yavuz I, Mentese A, Gunduz A, Karahan SC, et al. Differences in ischemia-modified albumin levels between end stage renal disease patients and the normal population. J Nephrol. 2010;23(3):335-40.
15. Ma SG, Wei CL, Hong B, Yu WN. Ischemia-modified albumin in type 2 diabetic patients with and without peripheral arterial disease. Clinics. 2011;66(10):1677-80.
16. Ma J, Zhang C, Zhang J, Hu J, Fang J, Zhang J, et al. Prospective study of first night effect on 2-night polysomnographic parameters in adult Chinese snorers with suspected obstructive sleep apnea hypopnea syndrome. Chin Med J. 2011;124(24):4127-31.
17. Jurado-Gamez B, Cabrera CB, Ballesteros LC, Hinojosa CM, Cabrera LM, Perez-Jimenez F, et al. Association of cellular adhesion molecules and oxidative stress with endothelial function in obstructive sleep apnea. Intern Med. 2012;51(4):363-8, http://dx.doi.org/10.2169/internal medicine.51.6571.
18. Lavie L. Obstructive sleep apnea syndrome-an oxidative stress disorder. Sleep Med Rev. 2003;7(1):35-51, http://dx.doi.org/10.1053/ smrv.2002.0261.
19. Volná J, Kemlink D, Kalousová M, Vávrová J, Majerová V, Mestek O, et al. Biochemical oxidative stress-related markers in patients with obstructive sleep apnea. Med Sci Monit. 2011;17(9):CR491-7, http://dx. doi.org/10.12659/MSM.881935.
20. Drager LF, Lopes HF, Maki-Nunes C, Trombetta IC, Toschi-Dias E, Alves MJ, et al. The impact of obstructive sleep apnea on metabolic and inflammatory markers in consecutive patients with metabolic syndrome. PLoS One; 2012;5(8):e12065.
21. Randell EW, Mathews MS, Zhang H, Seraj JS, Sun G. Relationship between serum butyrylcholinesterase and the metabolic syndrome. Clin Biochem. 2005;38(9):799-805, http://dx.doi.org/10.1016/j.clinbiochem. 2005.04.008.
22. Wiernsperger N, Nivoit P, Bouskela E. Obstructive sleep apnea and insulin resistance: a role for microcirculation? Clinics. 2006;61(3):253-66, http://dx.doi.org/10.1590/S1807-59322006000300011.
23. Yagihara F, Lucchesi LM, D'Almeida V, Mello MT, Tufik S, Bittencourt LR. Oxidative stress and quality of life in elderly patients with obstructive sleep apnea syndrome: are there differences after six months of Continuous Positive Airway Pressure treatment? Clinics. 2012;67(6):565-72, http://dx.doi.org/10.6061/clinics/2012(06)04.